Among both men and women, non-smokers and smokers, lung cancer remains the leading cause of cancer-related death. n recognition of Lung Cancer Awareness Month, Massachusetts General Hospital physicians answer common questions related to lung cancer.
In multi-year study, Mass General Cancer Center researchers found increase in rates for liver cancer deaths among Hispanic men and rates for liver, pancreatic, and uterine cancer deaths among Hispanic women.
A colon cancer diagnosis was no match for airline pilot and member of the Air National Guard, Rick Mastalerz. Read Rick and Sally’s patient story here.
New research led by investigators at Massachusetts General Hospital (MGH) reveals how cancer cells suppress anti-cancer immune responses in the lymph nodes to survive and spread, or metastasize.
Researchers at MGH have led and continue to lead studies that are defining the best use of proton therapy, which is now being offered at 106 centers worldwide.
Read a Women’s History Month Q&A with Mass General Cancer Center women in oncology who share their career journeys and advice for the next generation.
This was the first study evaluating the impact of hypofractionated radiotherapy for early lung cancer and the impact of the dose per fraction.
Results in mice suggest that combining drugs such as bevacizumab with chimeric antigen receptor–T cell therapy may benefit patients with glioblastoma.
Losartan may augment the benefits of other anti-cancer therapies by reducing tumor invasion and immunosuppression.
A new college grad diagnosed with adrenocortical carcinoma, Erin shares more about working and living with cancer as a young adult. Read her patient story.
The Massachusetts General Hospital Department of Radiation Oncology is a leader in developing and implementing some of the most innovative and effective radiation therapies in the world.
